Recently, study shows that drug resistance would be a major problem in the short term, than they were over climate change. Glance below to see more. Early this year, study that called for the Review on Antimicrobial Resistance, that was commissioned by the U.K. government amid growing concerns about drug-resistant “superbugs”, including new strains of E. coli, malaria and tuberculosis, estimated that, under the two scenarios modelled by RAND Europe and KPMG where both modelled an increase in AMR rates from where they are today, each using their own methodology, 300 million people are estimated to be dead before the usual time because of drug resistance over the next 35 years.


This will result to the world’s GDP (Gross domestic Product) being 2 to 3.5% lower than it otherwise would be in 2050. Basically, from now to 2050 the world can expect to lose between 60 and 100 trillion USD worth of economic productions, if antimicrobial drug resistance is not squarely tackled. This is equal to the loss of about one year’s total global output over the period, and will create significant and widespread poverty, according to CNBC reports.

In addition, in the nearer term we expect the world’s GDP to be 0.5% smaller by 2020 and 1.4% smaller by 2030 with more than 100 million premature deaths. Furthermore, the two modelled scenario also show distinct economic impact for each of the drug resistant infections which they considered, of which E. coli, malaria and TB are the huge drivers of the results. The result therefore shows that countries that already have high rate of malaria, HIV or TB  are likely to specifically suffer as resistance to recent treatments increases.

The particular countries that is facing the most significant risk include India, Nigeria, Indonesia (malaria) and Russia (TB). The study recommends that malaria and HIV drug resistance should be greatly tackled because Africa as a continent will suffer significantly and the bad impacts of HIV and TB already noticed in many of the poorest parts of the world will be made excerbated. Although Antibiotic use is increasing all over the world, the number of new antibiotics is falling. If these medicines become more ineffective, there could be a huge economic impediment, as people up to the working age are affected since resistant infections is currently estimated to cause 700,ooo deaths every year.

Drug resistance is the decrease in effectiveness of a drug such as an antimicrobial, anthelmintic or an antineoplastic in treating a disease or condition. More commonly, the term is used in the context of resistance that pathogens have “gained”, which implies that, resistance has developed. In a situation where by an organism resists more than one drug, it is said to be “multidrug-resistant”. Particularly, Antimicrobial resistance is the capacity of microbes, such as virus, parasites, bacteria or fungi to develop in the presence of drug that would normally treat or limits its development.

This occurs when microorganisms such as virus, bacteria, fungi, parasites change in ways that cause medications rendered for their treatment ineffective. When this happens, the microorganisms are called “superbugs”. This poses huge worry because a resistant infection may kill or spread to other and presents more costs to individual and society at large. More so, Microbes are single-cell organisms which are very tiny to the extent that millions can fit into the eye of a needle. They play a prominent role in our lives, however some microbes cause disease.